Increased frequency of LOH on chromosome 9 in sporadic primary melanomas is associated with increased patient age at diagnosis.

We carried out statistical analysis of the frequency of loss of heterozygosity (LOH) at 10 microsatellite markers on chromosome 9. In 44 microdissected sporadic primary melanomas a comparison of LOH frequency data with other patient data, like age at diagnosis and tumour thickness, showed an interesting correlation between patient age at diagnosis and frequency of LOH on chromosome 9. The patient group with age >72 years at diagnosis (n = 22, mean age 82.3 +/- 6.0 years, mean LOH 3.4 +/- 2.3) showed significantly increased LOH frequency (OR 3.1, 95% CI 1.8-5.3; chi(2) test, P < 0.0001) compared with age group </=72 years (n = 22, mean age 56.1 +/- 14.5 years, mean LOH 1.8 +/- 1.7). A statistically significant increased frequency of LOH (OR 3.5, 95% CI 1.5-7.9; chi(2) test, P = 0.03 after Bonferroni correction) was found only at marker D9S736 on 9p22 (telomeric to the INK4-ARF locus) relative to other markers on six different chromosomes. No other marker, including those located within the INK4-ARF locus, showed a statistically significant increased frequency of LOH. Our results for the first time show a non-random tendency for increased allelic loss in melanomas with increased patient age at diagnosis, besides supporting the existence of an additional tumour suppressor gene(s) on chromosome 9.

[1]  L. Sandkuijl,et al.  A locus linked to p16 modifies melanoma risk in Dutch familial atypical multiple mole melanoma (FAMMM) syndrome families. , 1999, Genome research.

[2]  K. Hemminki,et al.  Loss of heterozygosity at chromosome 9p21 (INK4-p14ARF locus): homozygous deletions and mutations in the p16 and p14ARF genes in sporadic primary melanomas. , 1999, Melanoma research.

[3]  D. Griffin,et al.  Functional evidence of novel tumor suppressor genes for cutaneous malignant melanoma. , 1999, Cancer research.

[4]  K. Kinzler,et al.  Genetic instabilities in human cancers , 1998, Nature.

[5]  Rajiv Kumar,et al.  Selective deletion of exon 1β of the p19ARF gene in metastatic melanoma cell lines , 1998, Genes, chromosomes & cancer.

[6]  Q. Wei.  Effect of aging on DNA repair and skin carcinogenesis: a minireview of population-based studies. , 1998, The journal of investigative dermatology. Symposium proceedings.

[7]  G. Walker,et al.  Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets , 1998, Genes, chromosomes & cancer.

[8]  X. Estivill,et al.  Retention of the CDKN2A locus and low frequency of point mutations in primary and metastasic cutaneous malignant melanoma , 1998, International journal of cancer.

[9]  E. Healy,et al.  Prognostic significance of allelic losses in primary melanoma , 1998, Oncogene.

[10]  K. Hemminki,et al.  Mutations in the CDKN2A ( p16INK4a ) gene in microdissected sporadic primary melanomas , 1998, International journal of cancer.

[11]  P. Waber,et al.  Genetic alterations of chromosome band 9p21 – 22 in head and neck cancer are not restricted to p16INK4a , 1997, Oncogene.

[12]  L Grossman,et al.  Epidemiology of ultraviolet-DNA repair capacity and human cancer. , 1997, Environmental health perspectives.

[13]  M. Bulyk,et al.  Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. , 1996, Cancer research.

[14]  C. Shields,et al.  Deletion mapping of chromosome region 9p21‐p22 surrounding the CDKN2 locus in melanoma , 1996, International journal of cancer.

[15]  E. Healy,et al.  Allelotypes of primary cutaneous melanoma and benign melanocytic nevi. , 1996, Cancer research.

[16]  D. Moore,et al.  The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosome painting. , 1995, Mutation research.

[17]  I. M. Jones,et al.  Impact of age and environment on somatic mutation at the hprt gene of T lymphocytes in humans. , 1995, Mutation research.

[18]  X. Estivill,et al.  Chromosome 9p deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the p16 (CDKN2) gene. , 1995, American journal of human genetics.

[19]  M. Skolnick,et al.  A cell cycle regulator potentially involved in genesis of many tumor types. , 1994, Science.

[20]  A. Halpern,et al.  Model predicting survival in stage I melanoma based on tumor progression. , 1989, Journal of the National Cancer Institute.

[21]  M. Ferguson-Smith,et al.  Essential medical genetics , 1987 .

[22]  W. Franklin,et al.  Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: the location of a putative tumor suppressor gene. , 1997, Cancer research.